Cleveland Diagnostics
Mr. Rochelle is Cleveland Diagnostics’ Chief Commercial Officer. Bob brings 30+ years of experience in novel healthcare product development and launch, strategy and marketing gained at start-ups such as Exact Sciences and Good Start Genetics, and established multinationals such as Abbott Labs, among others. He has launched, both domestically and internationally, successful pharmaceuticals (one with peak-year sales in the billions of dollars), medical devices and sophisticated DNA-based diagnostics (such as the DNA diagnostics lab that eventually became Genzyme Genetics, and the stool-DNA test for colorectal cancer, now marketed as Cologuard®). Bob holds a Bachelor of Science degree in Biology and Psychology from Trinity College (Hartford, CT) and a Masters of Business Administration from the Amos Tuck School of Business at Dartmouth College (Hanover, NH).
This person is not in any offices
Cleveland Diagnostics
1 followers
Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable.